Wyeth Hib vaccine shortage
Executive Summary
Wyeth expects to resume full supply of its Hib vaccine by the end of the year. Wyeth stopped manufacturing the product in the winter of 2002 because the supplier of its shipping vials went out of business. The company has found a new supplier and is building inventory. CDC indicated that Aventis and Merck have stepped up production to meet the supply gap; the Wyeth product represents 30% of the market...